We are pleased to announce that the Cancer Research Foundation (hereafter, Cancer Research Group) and Takeda Pharmaceutical Co., Ltd. (hereafter, Takeda Pharmaceutical) have recently signed an agreement on a development partnership in the cancer field. Based on this agreement, the Cancer Research Group and Takeda Pharmaceutical will conduct exchanges utilizing the strengths of both parties for the purpose of promoting global early clinical trials and promoting bridging research (translational research/reverse translational research), etc., and will share information and discuss necessary information and discussions on ongoing drug development. Through this, we aim to create excellent revolutionary anticancer drugs and deliver them to cancer patients and their families as soon as possible.
Regarding this development partnership, Mr. Toshio Asano, Chairman of the Cancer Research Group, said, “We are delighted to announce a global partnership related to research and development with Takeda Pharmaceuticals. I am convinced that Takeda Pharmaceutical, which has outstanding drug discovery research and development capabilities across the world, and the Cancer Research Group, which has a characteristic organization integrating hospital departments and research divisions, will walk together and move even closer to “overcoming cancer,” which is our philosophy.”
Phuong Khanh (P.K.) of Takeda Pharmaceutical's Oncology Therapeutic Area Unit Head Morrow said, “We are very happy with this partnership. We expect that by combining the clinical research knowledge of the Cancer Research Group with our clinical development capabilities, we will be able to demonstrate synergistic effects and advance the development of new treatments.”
The Cancer Research Group and Takeda Pharmaceutical will work to transform scientific progress into value for patients through co-creation.
What is the English press releaseHere
Please find the English press release from here
＜About the Cancer Research Foundation＞
The Cancer Research Foundation has set the basic philosophy of “contributing to human welfare by overcoming cancer,” and aims to clarify the nature and individuality of cancer, contribute to the diagnosis, treatment, and prevention of cancer, and pioneer the cutting edge of life science. To achieve this, we are actively conducting clinical trials (clinical trials) for new drug development and clinical research leading to the development of new treatments and diagnostic methods. We are also promoting so-called “translational research,” bridging basic research to the development of diagnosis/treatment methods. In 2019, we established an advanced medical development center specializing in early clinical development with the aim of becoming a leading clinical development base for next-generation cancer care in Japan. Furthermore, in 2022, we will establish an “Advanced Cancer Treatment Development Center” that integrates drug development support functions, and we are working to provide advanced cancer care to patients by promoting everything from basic research to clinical trials without interruption.
For more details, see https://www.jfcr.or.jp/index.htmlPlease see.
＜About Takeda Pharmaceuticals＞
Takeda Pharmaceutical Co., Ltd. (TSE:4502/NYSE:TAK) aims to contribute to the health and bright future of people around the world. We are working to create innovative pharmaceuticals in major disease areas and business fields such as digestive system/inflammatory diseases, rare diseases, plasma-fractionated preparations, oncology (cancer), neuroscience (neuropsychiatric diseases), and vaccines. Together with our partners, we are working to deliver new treatment options and contribute to improving patients' quality of life by building a strong and diverse pipeline. Takeda Pharmaceutical, headquartered in Japan, is a leading research and development biopharmaceutical company based on the value (value) of putting patients at the center based on its own corporate philosophy. Based on values that have been shaped for over 2 centuries, we are active in approximately 80 countries and regions to fulfill our raison d'être (purpose) in society. For more details,https://www.takeda.com/jp/Please see.